期刊文献+

肾移植患者sCD30的表达与急性排斥反应相关性的初步研究 被引量:3

The relationship between acute rejection and expression of sCD30 for the patients after kidney transplantation
原文传递
导出
摘要 目的研究sCD30与急性排斥反应的相关性。方法采用sCD30ELISA试剂盒(双抗体加心法)对58例首次肾移植患者术前1d、术后7d、28d进行了sCD30检测,31例健康者与术前1dsCD30做对照,并记录排斥反应的发生率。结果肾移植术前1dsCD30水平与急性排斥反应的相关性为X2=4.843,P<0.05,有显著性差异。肾移植术后第7天sCD30水平与急性排斥反应的相关性为X2=7.201,P<0.01,有高度显著性差异。肾移植术后第28天sCD30水平与急性排斥反应的相关性为X2=2.095,P<0.05,没有显著性差异。结论sCD30的高表达与急性排斥反应有关,sCD30在急性排斥反应中可能扮演了重要的角色。 Objective To study the relationship between the sCD30 and acute rejection.Methods We tested the sCD30 level in serum for 58 cases with kidney transplantation before and the 7th day and 28th day after operation by ELISA. 31 healthy individual for control group, and simultaneously recorded the incidence of rejection after kidney transplantation.Results The results showed that there is an obviously relation before kidney transplantation between the sCD30 level in serum and the incidence of acute rejection (chi=4.843,P=0.028, P<0.05). There is a significantly relation at the 7th day after kidney transplantation between the sCD30 level in serum and the incidence of acute rejection (chi=7.201,P=0.007, P<0.01). There is no obviously relation at 28 th day after kidney transplantation between the sCD30 level in serum and the incidence of acute rejection (chi=2.095,P=0.148, P>0.05).Conclusion The results suggested that the expressions of sCD30 are related to acute rejection. We speculated that the expressions of sCD30 could play an important role in acute rejection.
出处 《中华医学杂志》 CAS CSCD 北大核心 2005年第10期651-653,共3页 National Medical Journal of China
关键词 CD30 急性排斥反应 相关性 肾移植术后 术前 患者 表达 水平 心法 显著性差异 Kidney transplantation Graft rejection sCD30
  • 相关文献

参考文献11

  • 1Susal C, Pelzl S, Simon T, Opelz G. Advances in pre- and posttransplant immunologic testing in kidney transplantation. Transplant Proc,2004,36:29-34.
  • 2Pelzl S, Opelz G, Wiesel M,et al. Soluble CD30 as a predictor of kidney graft outcome. Transplantation,2002,15:73:3-6.
  • 3Pellegrini P, Berghella AM, Contasta I,et al. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response. Transpl Immunol,2003,12:49-61.
  • 4Caner Sual, Steffen Pelzl, Bernd D?hler,et al. Identification of Highly Responsive Kidney Transplant Recipients Using Pretransplant Soluble CD30. J Am Soc Nephrol,2002,13:1650-1656.
  • 5Romagnani S. The Th1/ Th2 paradigm . Immunol Today,1997, 18:263-266.
  • 6Schneider C, Hubinger G. Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family. Leuk Lymphoma. 2002,43:1355-1366.
  • 7Szabo S , Gighe AS , Gubler U , et al. Regulation of the IL-12Rβ2 subunit expression in developing T helper 1(Th1)and Th2 cells . J Exp Med , 1997,185 :817-824.
  • 8Nagata K,Tanaka K,Ogawa K,et al. Selective expression of a novel surface molecules by human Th2 cells in vivo. J Immunol, 1999, 162 :1278-1286.
  • 9Romagnani S. Role for CD30 antigen in human T helper 2-type responses. Ciba Found Symp, 1995,195:55-62.
  • 10Rush DN, Nickson P, Gough J, et al.Beneficial eefects of treatment of early subclinical rejection: a randomized study. J Amer Soc Nephrol,1998,9:2129-2134.

同被引文献34

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部